Back to top
more

Waters (WAT)

(Delayed Data from NYSE)

$352.51 USD

352.51
567,976

-1.89 (-0.53%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $352.48 -0.03 (-0.01%) 7:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Waters (WAT) Q1 Earnings Surpass Estimates, Sales Rise Y/Y

Waters' (WAT) first-quarter results reflect gains from a strong momentum across pharmaceutical and industrial end-markets, and geographical regions.

Waters (WAT) Q1 Earnings and Revenues Beat Estimates

Waters (WAT) delivered earnings and revenue surprises of 20.69% and 9.12%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) to Report Q1 Earnings: What's in the Cards?

Waters' (WAT) first-quarter 2022 results are likely to reflect solid momentum across pharmaceutical, industrial, and academic and government end markets.

Plexus (PLXS) Q2 Earnings and Revenues Beat Estimates

Plexus (PLXS) delivered earnings and revenue surprises of 14.46% and 5.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) Earnings Expected to Grow: Should You Buy?

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters (WAT) Expands Portfolio With Xevo TQ Absolute System

Waters (WAT) unveils the Xevo TQ Absolute system, which is up to 15 times more sensitive, 45% smaller in size, and consumes up to 50% less electricity and gas supply.

Here's Why Waters (WAT) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Waters (WAT) Boosts Its LC-MS Efforts With Latest Software

Waters (WAT) introduces the Intact Mass Software application on waters_connect and Waters MaxPeak Premier Protein BEH C4 300A Columns for biomolecule drug discovery and development.

Why Is Waters (WAT) Down 4.4% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Waters (WAT) Q4 Earnings Beat Estimates, Revenues Rise Y/Y

Waters' (WAT) fourth-quarter results reflect gains from a strong momentum across end-markets and geographical regions.

Waters (WAT) Tops Q4 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of 5.76% and 1.97%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) to Report Q4 Earnings: What's in the Cards?

Waters' (WAT) fourth-quarter 2021 results are likely to reflect solid momentum across pharmaceutical and industrial end markets.

Analysts Estimate Waters (WAT) to Report a Decline in Earnings: What to Look Out for

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters (WAT) Boosts Mass Spectrometry Via MS Quan Application

Waters (WAT) releases the MS Quan application on the waters_connect informatics software platform to help scientists efficiently screen large number of samples and contaminants.

Waters (WAT) Down 5.5% Since Last Earnings Report: Can It Rebound?

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Shilpa Mete headshot

Waters (WAT) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y

Waters' (WAT) third-quarter results reflect gains from strong momentum across pharmaceutical and industrial end-markets.

Waters (WAT) Beats Q3 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of 13.68% and 1.07%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) to Report Q3 Earnings: What's in the Cards?

Waters' (WAT) third-quarter 2021 results are likely to reflect strength across liquid chromatography instruments and mass spectrometers.

Waters (WAT) Earnings Expected to Grow: Should You Buy?

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Industry Outlook Highlights: Mettler-Toledo International, PerkinElmer and Waters Corp

Zacks Industry Outlook Highlights: Mettler-Toledo International, PerkinElmer and Waters Corp

Aniruddha Ganguly headshot

3 Stocks to Watch on Rising Demand for Scientific Instruments

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Waters Corporation (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand as well as rising healthcare spending.

Waters (WAT) BioAccord System to Expand Portfolio Offerings

Waters (WAT) introduces Waters BioAccord System with ACQUITY Premier for seamless monitoring of attributes of biotherapeutics.

Waters (WAT) Up 5.6% Since Last Earnings Report: Can It Continue?

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Waters (WAT) is a Great Momentum Stock: Should You Buy?

Does Waters (WAT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Can Waters (WAT) Run Higher on Rising Earnings Estimates?

Waters (WAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.